Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global ...

AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer ...

If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

Elevate your MedEd strategy with our 2025 toolkit! From AI-driven patient avatars to interactive augmented reality scenarios, ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to ...

Ardentia Ltd Ardentia has been providing world class business intelligence solutions to healthcare organisations since 1990. During this time we’ve gained a wealth of experience and a great ...

Caregivers often play an integral role during interactions with medical professionals ...

Political Intelligence is an independent European public affairs consultancy, with offices in London, Brussels, Madrid, Edinburgh and Rome. We provide our clients with practical public affairs advice ...

Gilead Sciences’ seladelpar has been recommended by the European Medicines Agency’s human medicines committee to treat the ...

Presenting your brand strategy for review by your most senior colleagues is a big deal, both professionally and personally.